MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/10790268.2024.2426314

Медицинская библиотека · The journal of spinal cord medicine · 2024

First report of a new exoskeleton in incomplete spinal cord injury: FreeGait®.

Şipal Meriç Selim, Yaşar Evren, Özişler Zuhal, Adıgüzel Emre, Yıldırım Sinem, Deler Ömür, Kirdiş Selin, Çelik Halil İbrahim, Uluşahin Seda Biçici, Kayalar Gülseren, Karaduman Aynur Ayşe

Клиническое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

CONTEXT: Intensive walking practice often demands capabilities that go beyond the limits for both patients and therapists. As a solution, robot-assisted exoskeletons have been developed to deliver efficient rehabilitation sessions.

OBJECTIVE

The primary aim was to evaluate the effect of adding exoskeleton training, the FreeGait®, to conventional treatment on walking status in patients with motor incomplete spinal cord injury. The secondary aim was to assess its impact on mobility, functional independence, and health-related quality of life.

METHODS

This study compared exoskeleton gait training with conventional therapy (RBCT) versus conventional therapy alone (CT). Fourteen participants with motor incomplete spinal cord injury were included, with seven in each group. Both groups had 40-minute conventional therapy sessions 5 days a week. Additionally, the RBCT performed exoskeleton walking and balance exercises 3 days a week. The WISCI II (primary outcome), 10MWT, gait speed, TUG, BBS, SCIM III, and WHOQOL-BREF were used for evaluation (see text for acronyms).

RESULTS

Walking status and mobility-related measures showed significant improvements in the RBCT (p < 0.05), whereas no significant differences were observed in the CT (p > 0.05). There was a significant difference in the physical health domain of the WHOQOL-BREF only in the RBCT. However, no significant differences were found in the WHOQOL-BREF total score in both groups (p > 0.05). Furthermore, no significant difference was observed between the groups in terms of change (p > 0.05).

CONCLUSIONS

Gait training with the new exoskeleton combined with conventional therapy, positively contributes to walking status, mobility, and functional independence.Trial registration: ClinicalTrials.gov identifier: NCT06137456.

Для цитирования: Şipal Meriç Selim, Yaşar Evren, Özişler Zuhal, Adıgüzel Emre, Yıldırım Sinem, Deler Ömür, Kirdiş Selin, Çelik Halil İbrahim, Uluşahin Seda Biçici, Kayalar Gülseren, Karaduman Aynur Ayşe. First report of a new exoskeleton in incomplete spinal cord injury: FreeGait®.. The journal of spinal cord medicine. 2024. DOI: 10.1080/10790268.2024.2426314.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.